Physician profile
Michael J Brewer
NPI 1629081708
$3,312.13
in general payments reported to CMS, 2019-2025
19 companies · $2,134 in 2025
The $2,134 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.55 · 2020: $509 · 2021: $71.60 · 2022: $148 · 2023: $161 · 2024: $247 · 2025: $2,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396 · Travel and Lodging: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.89 |
| Travel and Lodging | $1,146.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,558.34 | 2024-2025 | |
| The Walman Optical Company | $480.00 | 2020 | |
| Bausch & Lomb Americas INC. | $294.44 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $224.32 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $135.57 | 2020-2025 | Rocklatan, Precision 1, Total30 |
| Dompe US, INC. | $123.70 | 2022-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $105.38 | 2021-2023 | |
| Johnson & Johnson Vision Care, INC. | $94.25 | 2019-2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $74.06 | 2022-2025 | Cequa |
| Apellis Pharmaceuticals, INC. | $46.36 | 2025 | Syfovre |
| Coopervision INC. | $32.12 | 2025 | Clariti Contact Lens |
| Regeneron Healthcare Solutions, INC. | $28.50 | 2024 | Eylea, Eylea Hd |
| Oyster Point Pharma, INC. | $22.34 | 2024 | Tyrvaya |
| Harrow Eye, LLC | $18.71 | 2025 | Vevye |
| Abbvie INC. | $18.57 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.78 | 2021 | |
| Aerie Pharmaceuticals, INC. | $15.30 | 2021 | |
| Integra Lifesciences Corporation | $12.46 | 2022 | |
| Kala Pharmaceuticals, INC. | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.